Finding a Clinical Trial: What ClinicalTrials.gov Shows and What DecenTrialz Adds

Clinical trial participation begins with a search. For adults in the United States who want to explore joining a study, two tools most often come up: ClinicalTrials.gov, the official public registry run by the U.S. government, and DecenTrialz, a private platform that helps match participants with studies and pre-screens them before a research site visit. These two tools work differently, and they answer different needs. Understanding what each one offers, and how they fit together, saves time and reduces the frustration many people describe when they first try to find a trial on their own.

This side-by-side explains what ClinicalTrials.gov is, what patients typically encounter when they use it, what DecenTrialz adds on top of the registry, and how the two can be used together. Neither tool guarantees a place in a study. Both can help a patient move closer to one.

What ClinicalTrials.gov Is and What It Shows You

ClinicalTrials.gov is the official public registry of clinical studies operated by the U.S. National Library of Medicine (NLM), part of the National Institutes of Health (NIH). A registry, in this context, is a structured online database that lists key information about clinical studies so patients, doctors, and researchers can find them. The site has been publicly available since 2000, and U.S. law requires most interventional studies of drugs, biologics, and medical devices regulated by the Food and Drug Administration (FDA) to register there.

Each study on ClinicalTrials.gov has its own record. That record typically shows the study title, a unique identifier called an NCT number (the letters NCT followed by an eight-digit number), the study phase (an indicator of how advanced the testing is, from Phase 1 through Phase 4), the sponsor (the organization responsible for the study), the medical condition being studied, the intervention being tested, the eligibility criteria (the characteristics that determine who can and cannot join), the locations where the study is being conducted, and contact information for site staff. Many records also include summary results after the study ends.

Because the registry is government-run and free to use, it is widely considered the most authoritative source of information on clinical studies in the United States. It is also comprehensive. Very few U.S. interventional trials sit outside it. If a patient wants a complete map of active studies for a given condition, the registry is the right place to look. At many sites, the person who answers a patient's initial call is a nurse or coordinator known as a clinical research coordinator; see the role of a clinical research coordinator for a fuller description of that job.

What Patients Find Difficult When Searching the Registry Alone

The registry was designed for transparency and record-keeping, not for guided patient enrollment. Three points of friction come up again and again for people who try to use it on their own.

First, the eligibility criteria for most studies are written in the same technical language used in regulatory documents. A single study record may list dozens of inclusion and exclusion rules referencing lab values, prior therapies, generic drug classes, imaging findings, or specific medical histories. A general reader without a clinical background often cannot tell whether a criterion applies to them personally.

Second, the volume is high. A search for a common condition can return hundreds or thousands of records across dozens of states. Filtering by location and recruitment status narrows the list, but the reader is still left comparing many trials on their own.

Third, the registry does not do any pre-screening. There is no intake form and no shortlist. A patient who wants to know whether they might qualify has to call or email the contact listed on each study record. Contact information can also be dated, and a record's recruitment status may lag behind what is happening on the ground. That helps explain why screened patients may not enroll even after they invest time and travel.

None of this makes ClinicalTrials.gov less trustworthy. It simply reflects what the registry was built to do: publish accurate records of clinical studies for public reference, not walk each visitor through the search.

What DecenTrialz Adds to the Search

DecenTrialz is a U.S.-based clinical trial recruitment and pre-screening platform. It uses AI-assisted matching to narrow a large pool of studies down to a short list that appears relevant to a specific participant, and it uses registered nurse-led (RN-led) pre-screening to have a real conversation with that person before a research site visit is scheduled. Pre-screening is an early check of likely eligibility. It is not a final decision.

Instead of asking a patient to read eligibility criteria in raw regulatory language, DecenTrialz collects basic information through a plain-language intake questionnaire. AI-assisted matching then compares that information against studies from sponsors and research sites that work with the platform. A registered nurse follows up to explain what participation would involve, answer questions, and check whether it makes sense to send that person forward to a site. If the fit looks reasonable, DecenTrialz makes a warm handoff to the research site team.

DecenTrialz pre-screens only. The research site team handles final eligibility determination, informed consent, study walk-through, and enrollment. That boundary matters. A recruiter cannot decide who joins a study; only the authorized study team at a research site can do that, after a formal screening visit and consent process. For a walk-through of the intake experience, see how to search and apply on the platform.

DecenTrialz also has an honest limit. It surfaces only studies from sponsors and sites it works with, so its coverage of the U.S. trial landscape is narrower than the registry's. The registry remains the exhaustive source of record, and the two are meant to work together rather than replace each other.

A Side-by-Side View for Patients

The differences between the two tools come down to what each one is built for.

On coverage, ClinicalTrials.gov holds records for virtually all U.S. interventional trials, while DecenTrialz shows only studies from sponsors and research sites it works with. On cost, both are free to the patient; participants generally do not pay a recruitment platform, and clinical trial participation itself typically does not carry out-of-pocket costs for the study intervention or study procedures.

On guidance, ClinicalTrials.gov is self-serve. A visitor searches, filters, reads criteria, and then contacts each site individually. DecenTrialz is a guided service. An intake questionnaire, AI-assisted matching, and a conversation with a registered nurse do part of that legwork before a patient makes any calls.

On neutrality and authority, ClinicalTrials.gov is the neutral, government-run record of studies. DecenTrialz is a private platform that curates matches from within its network. That difference matters when a patient wants to verify that a specific study exists and to see its full official record, including the exact eligibility criteria and results once they are available. Before any research site visit, the study team will share the study's official documents. Understanding those documents, especially the consent form, is part of preparing well; see the guidance on reading the informed consent form.

How to Use ClinicalTrials.gov and DecenTrialz Together

The two tools are complementary. A practical way to use them together is to start with whichever feels easier and cross-check with the other.

A patient who prefers guided help can start with DecenTrialz. Complete the intake questionnaire, receive an AI-generated short list, and speak with a nurse to review the top matches. If a specific study looks promising, look it up on ClinicalTrials.gov by NCT number or title to see the full official record: sponsor, all inclusion and exclusion criteria, primary and secondary outcome measures, and complete site locations. That cross-check helps confirm the study is active and lets the patient bring specific questions to the pre-screening conversation.

A patient who prefers to search independently can start with ClinicalTrials.gov. Filter by condition, recruitment status, and location; review the study record; and note the NCT number of any study that looks like a fit. Then use DecenTrialz to see whether a match is available in its network and to have a nurse help interpret eligibility before contacting a site.

Whichever direction the search takes, the next step for any promising study is the same: a formal screening visit at the research site. That visit follows a defined process, and preparing for it makes a meaningful difference; see what your first screening visit involves before showing up.

Common Questions Patients Ask

Is ClinicalTrials.gov trustworthy?

Yes. ClinicalTrials.gov is operated by the U.S. National Library of Medicine at the National Institutes of Health. It is the official U.S. public registry of clinical studies. Individual study records are submitted by the sponsor or investigator responsible for each study, and the registry displays those records so patients, doctors, and researchers can find and review them.

Does it cost anything to use ClinicalTrials.gov or DecenTrialz?

No. ClinicalTrials.gov is a free government service. Participants also do not pay to use a clinical trial recruitment platform, and joining a clinical trial itself typically does not require out-of-pocket payment for the study intervention or study procedures.

Can a patient use both at the same time?

Yes. The two tools serve different purposes and can be used side by side. Many patients start with one, find a study that looks interesting, and use the other to verify details or get more support before contacting a site.

Which one should a patient start with?

There is no single right answer. A patient who wants a guided intake and a conversation with a nurse before any site call may prefer to start with DecenTrialz. A patient who wants to see the full universe of studies for a condition, or who is checking a specific study by name, may prefer to start with ClinicalTrials.gov. Using both is often the most complete approach.

Does either tool decide who gets into a study?

No. Neither tool enrolls anyone. Final eligibility determination and enrollment are handled by the study team at the research site conducting the trial, after a formal screening visit and the informed consent process.

A Complete Picture for Patients Exploring a Clinical Trial

ClinicalTrials.gov and DecenTrialz answer different parts of the same question. The registry gives a patient the full map of studies in the United States, with the authority of a government source and the depth of an official record. DecenTrialz turns a slice of that map into a guided path, with plain-language intake, AI-assisted matching, and a nurse conversation before any site visit is scheduled. Used together, they help a patient move from broad searching to a shorter list of studies worth a serious look, while leaving all medical decisions and final enrollment with the research site team.